U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Corifact
  1. Approved Blood Products

STN#: BL 125385
Proper Name: Factor XIII Concentrate (Human)
Trade Name: Corifact
Manufacture: CSL Behring, GmbH
Indication: Indicated for the routine prophylactic treatment and the peri-operative management of surgical bleeding in adult and pediatric patients with Congenital Factor XIII deficiency.

Product Information

Supporting Documents

Back to Top